Cryosite Ltd Cash Flow Conversion Efficiency
Cryosite Ltd cash flow conversion efficiency. Based on the latest financial reports, Cryosite Ltd (CTE) has a cash flow conversion efficiency ratio of 0.361x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$1.30 Million ≈ $921.96K USD) by net assets (AU$3.61 Million ≈ $2.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cryosite Ltd (2001–2025)
Cash flow conversion efficiency of Cryosite Ltd from 2001 to 2025. This chart illustrates how Cryosite Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CTE live share price for real-time trading data and today's change.
Cryosite Ltd Cash Flow Conversion Ratio Explained
Cryosite Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cryosite Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cryosite Ltd ranked by their cash flow conversion efficiency. Also see market value of Cryosite Ltd for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Fuel Tech Inc
NASDAQ:FTEK
|
-0.024x |
|
Datacentrex, Inc.
NASDAQ:DTCX
|
-0.041x |
|
ECA
KLSE:0267
|
0.036x |
|
Suratwwala Business Group Limited
NSE:SBGLP
|
0.004x |
|
SMS Lifesciences India Limited
NSE:SMSLIFE
|
0.153x |
|
Sea & Land Integrated Co
TWO:5603
|
0.023x |
|
Exel Composites Oyj
HE:EXL1V
|
0.102x |
|
Unibios Holdings S.A
AT:BIOSK
|
0.017x |
Annual Cash Flow Conversion Efficiency for Cryosite Ltd (2001–2025)
The table below shows the annual cash flow conversion efficiency of Cryosite Ltd from 2001 to 2025. Review cash generation quality of Cryosite Ltd to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$2.39 Million ≈ $1.69 Million |
AU$2.06 Million ≈ $1.46 Million |
0.864x | -54.36% |
| 2024-06-30 | AU$1.45 Million ≈ $1.03 Million |
AU$2.74 Million ≈ $1.94 Million |
1.893x | +274.03% |
| 2023-06-30 | AU$2.78 Million ≈ $1.97 Million |
AU$1.41 Million ≈ $996.25K |
0.506x | -62.25% |
| 2022-06-30 | AU$1.86 Million ≈ $1.32 Million |
AU$2.49 Million ≈ $1.77 Million |
1.341x | +130.27% |
| 2021-06-30 | AU$819.23K ≈ $579.65K |
AU$476.96K ≈ $337.48K |
0.582x | -93.10% |
| 2020-06-30 | AU$154.88K ≈ $109.58K |
AU$1.31 Million ≈ $924.35K |
8.435x | +2135.42% |
| 2019-06-30 | AU$-1.72 Million ≈ $-1.21 Million |
AU$-647.54K ≈ $-458.17K |
0.377x | +379.99% |
| 2018-06-30 | AU$1.94 Million ≈ $1.38 Million |
AU$-261.91K ≈ $-185.32K |
-0.135x | -126.08% |
| 2017-06-30 | AU$3.15 Million ≈ $2.23 Million |
AU$1.63 Million ≈ $1.15 Million |
0.517x | +267.77% |
| 2016-06-30 | AU$3.38 Million ≈ $2.39 Million |
AU$474.61K ≈ $335.82K |
0.140x | -64.86% |
| 2015-06-30 | AU$3.54 Million ≈ $2.51 Million |
AU$1.42 Million ≈ $1.00 Million |
0.400x | +54.74% |
| 2014-06-30 | AU$6.14 Million ≈ $4.34 Million |
AU$1.58 Million ≈ $1.12 Million |
0.258x | -16.57% |
| 2013-06-30 | AU$6.26 Million ≈ $4.43 Million |
AU$1.94 Million ≈ $1.37 Million |
0.310x | -9.74% |
| 2012-06-30 | AU$5.48 Million ≈ $3.88 Million |
AU$1.88 Million ≈ $1.33 Million |
0.343x | +13.39% |
| 2011-06-30 | AU$4.69 Million ≈ $3.32 Million |
AU$1.42 Million ≈ $1.00 Million |
0.303x | +34.76% |
| 2010-06-30 | AU$4.35 Million ≈ $3.08 Million |
AU$977.66K ≈ $691.75K |
0.225x | +37.27% |
| 2009-06-30 | AU$4.34 Million ≈ $3.07 Million |
AU$709.86K ≈ $502.27K |
0.164x | -20.44% |
| 2008-06-30 | AU$4.32 Million ≈ $3.06 Million |
AU$888.27K ≈ $628.51K |
0.206x | +10.08% |
| 2007-06-30 | AU$3.74 Million ≈ $2.64 Million |
AU$697.65K ≈ $493.63K |
0.187x | +358.76% |
| 2006-06-30 | AU$2.81 Million ≈ $1.99 Million |
AU$-203.02K ≈ $-143.65K |
-0.072x | +10.55% |
| 2005-06-30 | AU$2.48 Million ≈ $1.75 Million |
AU$-199.90K ≈ $-141.44K |
-0.081x | +66.81% |
| 2004-06-30 | AU$3.04 Million ≈ $2.15 Million |
AU$-738.72K ≈ $-522.69K |
-0.243x | +20.88% |
| 2002-06-30 | AU$3.89 Million ≈ $2.75 Million |
AU$-1.20 Million ≈ $-845.61K |
-0.307x | -27.31% |
| 2001-06-30 | AU$3.87 Million ≈ $2.74 Million |
AU$-933.52K ≈ $-660.52K |
-0.241x | -- |
About Cryosite Ltd
Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial … Read more